Two in one: simultaneous use of two long-acting antipsychotics in schizophrenia

Marek Jarema

eISSN: 2449-9315
ISSN: 1234-8279

Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Without publication fees

Open access

1/2021
vol. 37

Send email

Copy url:

Review paper

Two in one: simultaneous use of two long-acting antipsychotics in schizophrenia

Marek Jarema

¹

3rd Department of Psychiatry, Institute of Psychiatry and Neurology in Warsaw, Poland

Farmakoterapia w Psychiatrii i Neurologii 2021, 37 (1), 45–51

Online publish date: 2021/11/17

Article file

- 03R_IPiN_FARM_2021-1C.pdf [0.10 MB]

Get citation

1. Biagi E, Capuzzi E, Colmegna F, Mascarini A, Brambilla G, Ornaghi A, Santambrogio J. Long-acting injectable antipyschotics in schizophrenia: literature review and practical perspective with focus on aripiprazole once-monthly. Adv Ther. 2017; 34: 1036-1048.

2. Ceylan MF, Erdogan B, Hesapcioglu ST. Effectiveness, adverse effects and drug compliance of Long-acting Injectable risperidone in children and adolescents. Clin Drug Investing 2017; 37: 947-956.

3. Diefendorfer LA. When should you consider combining 2 long-acting injectable antipsychotics? Curr Psychiatry 2017; 16: 42-46.

4. Jarema M (red.). Standardy leczenia farmakologicznego niektórych zaburzeń psychicznych. Via Medica, Gdańsk 2015.

5. Jarema M, Bieńkowski P, Heitzman J, Parnowski T, Rybakowski J. Palmitynian paliperidonu: skuteczność, bezpieczeństwo stosowania i miejsce w leczeniu schizofrenii. Psychiatr. Pol. 2017, 51: 7-21.

6. Jarema M, Wichniak A. Long-acting aripiprazole in the treatment of schizophrenia; practical aspects. Pharmacol. Psychiatry Neurol. 2017, 32: 145-165.

7. Jarema M, Wichniak A, Dudek D, Samochowiec J, Bieńkowski P, Rybakowski J. Second-generation long-acting antipsychotics: when to use and how. Farmakother. Psychiatr. Neurol. 2015; 31: 57-66 (a).

8. Jarema M, Wichniak A, Dudek A, Samochowiec J, Bieńkowski P, Rybakowski J. Wskazówki do stosowania leków przeciwpsychotycznych II generacji o przedłużonym działaniu. Psychiatr. Pol. 2015; 49: 225-242 (b).

9. Ladds B, Cosme R, Rivera F. Concurrent use of two depot antipsychotic medications in schizophrenia. Internet J Psychiatry 2019.

10. Malinowska-Kubiak M, Permoda-Osip A. Zastosowanie trzech leków przeciwpsychotycznych w iniekcjach o przedłużonym działaniu u pacjentka z objawami psychotycznymi w przebiegu choroby choroby Huntingtona – opis przypadku. Farm Psych Neurol 2017; 33: 67-75.

11. Mathew C, Venkatesh SA, Tirupati S. Use of two long-acting injectable antipsychotics for treatment-resistant schizophrenia. Aust N Z J Psychiatry 2018; 52: 1098-1099.

12. McInnis P, Kasinathan J. Combination long-acting injectable (LAI) antipsychotic medication in adolescents with severe psychosis and aggression: a case series. Austr Psychiatry 2019; 27: 160-267.

13. Meltzer HY, Alphs L, Green AI, Altamura AC, Anland R, Bertoldi A i wsp. Clozapine treatment for suicidality in schizophrenia – International Suicide Prevention Trial. Arch Gen Psychiatry 2003; 60: 82-91.

14. Pacchiarotti I, Tiihonen J, Kotzalidis GD, Verdolini N, Murru A, Goikolea JM i. wsp.: Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: a systematic review. Eur Neuropsychophamacol 2019; 29: 457-470.

15. Pompili M, Orsolini L, Lamis DA, Goldsmith DR, Nardella A, Falcone G i wsp. Suicide prevention in schizophrenia: do long-acting injectable antipsychotics (LAIs) have a role? CNS Neurol Disord Drug Targets 2017; 16: 454-462.

16. Sengul C, Kalkanci O, Simsek D, Herken H. Maintenance electroconvulsive therapy combined with long-acting risperidone in the treatment of resistant bipolar affective disorder. Journal ECT 2009; 25: 282.

Two in one: simultaneous use of two long-acting antipsychotics in schizophrenia

Marek Jarema 1

Marek Jarema

¹